Michael Ochse
38Patents
7h-index
43Co-inventors
65Inventor score
Filing activity: Feb 15, 2005 → May 10, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8642587B2 | Heterocyclic compounds, pharmaceutical compositions containing them, and their use in therapy | Chemistry; Metallurgy | 60 | Active |
| US8431604B2 | Guanidine compounds, and use thereof as binding partners for 5-HT5 receptors | Chemistry; Metallurgy | 35 | Active |
| US9273068B2 | Substituted isoquinolines and phthalazines as inhibitors of phosphodiesterase type 10A | Chemistry; Metallurgy | 25 | Active |
| US8420670B2 | 4-benzylaminoquinolines, pharmaceutical compositions containing them, and their use in therapy | Chemistry; Metallurgy | 17 | Active |
| US8653100B2 | Tetrahydroisoquinolines, pharmaceutical compositions containing them, and their use in therapy | Chemistry; Metallurgy | 17 | Active |
| US8481576B2 | Guanidine compounds, and use thereof as binding partners for 5-HT5 receptors | Chemistry; Metallurgy | 16 | Active |
| US8563617B2 | Aminotetraline derivatives, pharmaceutical compositions containing them, and their use in therapy | Chemistry; Metallurgy | 12 | Active |
| US8686002B2 | Heterocyclic compounds and their use as binding partners for 5-HT5 receptors | Chemistry; Metallurgy | 4 | Active |
| US10556914B2 | Substituted isoxazolopyridazinones and isothiazolopyridazinones and methods of use | Chemistry; Metallurgy | 4 | Active |
| US9938269B2 | Inhibitor compounds of phosphodiesterase type 10A | Chemistry; Metallurgy | 4 | Active |
| US9828381B2 | Substituted pyrazolopyrimidines and method of use | Chemistry; Metallurgy | 3 | Active |
| US9388180B2 | Inhibitor compounds of phosphodiesterase type 10A | Chemistry; Metallurgy | 3 | Active |
| US9200005B2 | Inhibitor compounds of phosphodiesterase type 10A | Human Necessities | 2 | Active |
| US9163019B2 | Inhibitor compounds of phosphodiesterase type 10A | Chemistry; Metallurgy | 1 | Active |
| US9790203B2 | Inhibitor compounds of phosphodiesterase type 10A | Chemistry; Metallurgy | 1 | Active |
| US8846743B2 | Aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy | Chemistry; Metallurgy | 1 | Active |
| US9051280B2 | Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy | Chemistry; Metallurgy | 1 | Active |
| US9856220B2 | Inhibitor compounds of phosphodiesterase type 10A | Chemistry; Metallurgy | 1 | Active |
| US8883839B2 | Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy | Chemistry; Metallurgy | 1 | Active |
| US8957089B2 | Tetrahydroisoquinolines, pharmaceutical compositions containing them, and their use in therapy | Chemistry; Metallurgy | 1 | Active |
| US10280159B2 | Fused (hetero)cyclic compounds as S1P modulators | Chemistry; Metallurgy | 0 | Active |
| US9045459B2 | Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy | Chemistry; Metallurgy | 0 | Active |
| US9365512B2 | Isoindoline derivatives, pharmaceutical compositions containing them, and their use in therapy | Chemistry; Metallurgy | 0 | Active |
| US10556907B2 | Fused heterocyclic compounds as S1P modulators | Chemistry; Metallurgy | 0 | Active |
| US8921406B2 | 5-ring heteroaromatic compounds and their use as binding partners for 5-HT5 receptors | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.